Otsuka (OTCMKTS:OTSKY) Shares Gap Up After Better-Than-Expected Earnings

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) shares gapped up prior to trading on Monday after the company announced better than expected quarterly earnings. The stock had previously closed at $34.4080, but opened at $36.44. Otsuka shares last traded at $36.5050, with a volume of 8,919 shares traded.

The company reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a return on equity of 12.93% and a net margin of 15.50%.The firm had revenue of $4.41 billion during the quarter, compared to analyst estimates of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS.

Otsuka Trading Up 6.1%

The company has a quick ratio of 1.67, a current ratio of 2.17 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $39.21 billion, a P/E ratio of 14.66, a PEG ratio of 7.60 and a beta of -0.04. The firm’s 50-day simple moving average is $34.15 and its 200 day simple moving average is $33.55.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.